A phase 1 dose-escalation study of a PD-L1xCD27 bispecific antibody CDX-527 in patients with advanced malignancies.Rachel E. Sanborn,Rodolfo Eduardo Bordoni,Gini F. Fleming,Mustafa Khasraw,Thomas Hawthorne,Lawrence J. Thomas,Tracey Rawls,Diane C. Young,Philip Golden,Tibor Keler,Michael Jay YellinJOURNAL OF CLINICAL ONCOLOGY(2021)引用 2|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要